ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Headache,Headaches NEC,Headaches,Nerv,N
2,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
9,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
10,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
10,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
10,3,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
10,4,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
11,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
11,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
12,1,Headache,Headaches NEC,Headaches,Nerv,N
12,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
12,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
12,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
13,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
13,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
13,3,Headache,Headaches NEC,Headaches,Nerv,N
13,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
13,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
13,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
13,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
14,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
15,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
16,1,Headache,Headaches NEC,Headaches,Nerv,N
16,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
17,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
18,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
20,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
20,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
21,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,2,Headache,Headaches NEC,Headaches,Nerv,N
21,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
21,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
21,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
22,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
24,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
25,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Migraine,Migraine headaches,Headaches,Nerv,N
25,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
26,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
26,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
26,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,3,Headache,Headaches NEC,Headaches,Nerv,N
27,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
29,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
30,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
33,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
34,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
34,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
36,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
37,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
38,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
39,1,Migraine,Migraine headaches,Headaches,Nerv,N
40,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
41,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
42,1,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
42,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
43,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
44,1,Migraine,Migraine headaches,Headaches,Nerv,N
45,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
46,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
46,2,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
47,1,Breast inflammation,Breast infections and inflammations,Breast disorders,Repro,N
47,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
48,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
49,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
50,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
51,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
52,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
53,1,Acne,Acnes,Skin appendage conditions,Skin,N
54,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
56,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
57,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
57,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
59,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
60,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
61,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
62,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
63,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
64,1,Acne,Acnes,Skin appendage conditions,Skin,N
64,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
66,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
68,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
68,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
69,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
69,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
71,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
71,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
71,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
71,4,Headache,Headaches NEC,Headaches,Nerv,N
71,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
73,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
73,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
73,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
73,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
73,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
73,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
73,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
73,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
74,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
75,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
76,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
76,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
76,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
76,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
77,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
78,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
78,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
79,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
81,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
82,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
85,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
86,1,Application site photosensitivity reaction,Application site reactions,Administration site reactions,Genrl,N
87,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
88,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
89,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
90,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
90,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
91,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
91,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
92,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
93,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
94,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
94,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
95,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
97,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
99,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
101,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
102,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
102,2,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
103,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
104,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
106,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,1,Pregnancy with contraceptive device,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
107,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
108,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
109,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
112,1,Device failure,Device issues NEC,Device issues,Prod,N
113,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
113,2,Headache,Headaches NEC,Headaches,Nerv,N
113,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
113,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
113,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
114,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
114,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
118,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
119,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
119,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
120,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
123,1,Device ineffective,Device issues NEC,Device issues,Prod,N
123,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,1,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
125,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
126,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
126,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
128,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,1,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
130,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
130,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
130,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
130,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
131,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
132,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
133,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
134,1,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
134,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
135,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
136,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
136,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
137,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
137,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
137,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
137,5,Migraine,Migraine headaches,Headaches,Nerv,N
138,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
138,2,Headache,Headaches NEC,Headaches,Nerv,N
138,3,Migraine,Migraine headaches,Headaches,Nerv,N
138,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
139,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
140,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
141,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
143,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
144,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
144,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
144,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
146,1,Migraine,Migraine headaches,Headaches,Nerv,N
147,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
147,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
148,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
149,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Device failure,Device issues NEC,Device issues,Prod,N
151,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
151,2,Arrested labour,Failed labour,Maternal complications of labour and delivery,Preg,N
151,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
151,4,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
152,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
153,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
154,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
154,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
154,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
154,4,Migraine with aura,Migraine headaches,Headaches,Nerv,N
154,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
154,8,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
154,9,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
154,10,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
155,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
155,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
155,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
155,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
155,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
155,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
155,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,9,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
155,10,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
155,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
156,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
156,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,3,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
157,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
158,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
159,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
160,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
162,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
162,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
162,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
163,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
163,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
164,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
165,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
165,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
165,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
167,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
168,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
169,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
169,2,Vaginal dysplasia,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
170,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
171,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
171,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
173,1,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
174,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
175,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
176,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
177,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
178,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
179,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
180,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
180,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
181,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
181,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
182,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
182,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
182,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
183,1,Anaphylactoid shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
183,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
184,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
185,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
186,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,2,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
186,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
187,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
187,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
189,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
190,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
190,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
190,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
190,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
191,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
191,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
191,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
192,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
192,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
193,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
193,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
194,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
194,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
195,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
195,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
196,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
197,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
197,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
198,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
198,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
198,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
198,5,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
198,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,7,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
198,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
199,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
200,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
201,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
201,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
202,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
202,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
202,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
202,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
203,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
203,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
203,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
204,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
204,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
204,3,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
204,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
204,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
205,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
206,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
206,2,Migraine,Migraine headaches,Headaches,Nerv,N
206,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
206,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
208,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
209,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
210,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
210,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
212,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
212,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
213,2,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
214,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
215,1,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
216,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
217,1,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
218,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
218,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
218,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
218,4,Headache,Headaches NEC,Headaches,Nerv,N
218,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
218,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
219,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
220,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
221,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
221,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
222,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
222,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
222,3,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
222,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
223,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
223,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
223,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
223,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
223,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
223,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
223,8,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
223,9,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
224,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
224,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
224,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
224,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
225,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
226,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
227,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
227,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
228,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
229,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
230,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
230,2,Application site papules,Application site reactions,Administration site reactions,Genrl,N
231,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
231,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
231,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
231,5,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
231,6,Headache,Headaches NEC,Headaches,Nerv,N
231,7,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
231,8,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
232,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
233,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
234,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
234,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
235,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
235,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
236,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
237,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
238,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
238,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
239,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
239,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
239,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
239,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
239,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
239,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
240,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
241,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
241,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
241,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
241,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
241,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
241,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
241,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
243,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
243,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
244,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
244,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
244,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
244,4,Right ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
245,1,Coital bleeding,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
246,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
247,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
247,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
248,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
249,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
250,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
251,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
251,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
251,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
251,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
252,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
252,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
252,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
252,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
252,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
252,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
253,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
253,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
253,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
253,4,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
253,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
253,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
253,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
255,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
256,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
256,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
257,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
257,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
257,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
257,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
258,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
258,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
260,1,Headache,Headaches NEC,Headaches,Nerv,N
261,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
262,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
263,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
263,2,Pregnancy with contraceptive patch,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
264,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
264,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
265,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
266,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
266,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
266,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
267,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
268,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
268,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
268,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
269,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
269,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
269,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
270,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
270,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
271,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,2,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
272,3,Headache,Headaches NEC,Headaches,Nerv,N
272,4,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
273,1,Bartholin's cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
273,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
274,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
275,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
276,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
277,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
277,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
277,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
278,1,Abnormal menstrual clots,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
279,1,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
280,1,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
281,1,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
282,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
283,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
283,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
283,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
284,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
285,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
285,3,Headache,Headaches NEC,Headaches,Nerv,N
285,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
285,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
286,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
287,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
289,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
289,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
289,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
290,1,Decidual cast,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
291,1,Decidual cast,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
292,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
292,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
292,3,Poor milk ejection reflex,Lactation disorders,Breast disorders,Repro,N
293,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
293,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
294,1,Decidual cast,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
295,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
296,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
297,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
298,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
298,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
299,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
300,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
301,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
302,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
303,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
303,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
303,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
304,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
305,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
306,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
307,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
308,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
309,1,Decidual cast,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
310,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
311,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
311,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
312,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
312,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
312,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
313,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
314,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
314,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
314,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
315,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
315,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
317,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
317,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
318,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
318,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
318,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
318,4,Headache,Headaches NEC,Headaches,Nerv,N
318,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
318,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
319,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
319,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
319,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
320,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
320,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
320,4,Headache,Headaches NEC,Headaches,Nerv,N
320,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
320,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
320,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
321,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
322,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
323,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
325,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
325,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
327,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,2,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
328,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
329,1,Headache,Headaches NEC,Headaches,Nerv,N
329,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
331,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
331,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
332,2,Application site scar,Application site reactions,Administration site reactions,Genrl,N
332,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
333,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
333,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
333,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
334,1,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
